Table 4. Summary of measures of association between herpes zoster ophthalmicus and cardiovascular events in reviewed studies.
Outcome | Reference | Follow Up Period After HZO |
n Events / n with HZ |
Adjustment Variables | Measure of Association* | Adjusted Association Size (95% CI) |
---|---|---|---|---|---|---|
Cerebrovascular Events | ||||||
Stroke (Non-Specified) |
Schink et al. | 3 months | 31* | AGE | IRR | 1.59 (1.10 to 2.32) |
Langan et al. | 4 months | 22* | AGE | IR | 3.38 (2.18 to 5.24) | |
Kang et al. | 1 year | 7 / 120 | AGE, SEX, HTN, DM, CHD, HYPLYP, RENAL, AF, HF, VALV, CRTD, INC, URBN, GEO | HR | 4.28 (2.01 to 9.03) | |
Lin et al. | 1 year | 53 / 658 | AGE, SEX, HTN, HYPLIP, DM, CHD, RHD, MEDS | HR | 4.52 (2.45 to 8.33) | |
Breuer et al. | 24 years | 68 / 1,710 | AGE, SEX, BMI, SMK, DYSLIP, HTN, DM, CHD, AF, PVD, CRTD, VALV | HR | 1.03 (0.77 to 1.39) | |
Ischemic Stroke | Minassian et al. | 1 week | 93* | AGE | IR | 2.73 (2.22 to 3.35) |
Minassian et al. | 3 months | 326* | AGE | IR | 1.29 (1.15 to 1.44) | |
Schink et al. | 3 months | 27* | AGE | IRR | 1.57 (1.05 to 2.35) | |
Hemorrhagic Stroke | Schink et al. | 3 months | 4* | AGE | IRR | 1.82 (0.62 to 5.37) |
Coronary Events | ||||||
Myocardial Infarction | Minassian et al. | 1 week | 43 (SCCS) | AGE | IR | 2.06 (1.52 to 2.79) |
* Comparison of patients with herpes zoster to those without (referent group)
Abbreviations (Alphabetically): AF: atrial fibrillation, BMI: body mass index, CLIN: frequency of clinical visits, CNCR: cancer, CRTD: carotid disease, CHD: coronary heart disease, COPD: chronic obstructive pulmonary disease, CVD: cerebral vascular disease, DEP: depression, DM: diabetes mellitus, GEO: geographical region, HF: heart failure: HR: hazard ratio, HYPLIP: hyperlipidemia, HTN: hypertension, HZ: Herpes Zoster, INC: income, IR: incidence ratio, IRR: incidence rate ratio, MEDS: medication use, NR: not reported, OCC: occupation, PVD: peripheral vascular disease, RENAL: renal disease, SSN: season, SMK: smoking statin, URBN: urbanization level of patient’s area of residence, VALV: valvular disease